Research Studies

Featured Research

Research has been an integral strength of the Center for Health Policy (CHP) since its founding. Faculty associated with the Center for Health Policy conduct real-world studies aimed at helping clinicians, administrators, and policymakers improve the population’s health equitably and efficiently. These studies address questions across the continuum of care including primary care practices, home health care, hospitals, school health, nursing homes, and public health departments.

In Fiscal Year 2018, the CHP was an active participant in obtaining more than $8 million in federal and foundation funding. Selected grant titles and brief synopsis include:

Comparative and Cost-Effectiveness Research Training for Nurse Scientists (CER2)

Multiple Principal Investigators: Stone, Pincus

This grant (NIH 5T32NR014205-07) provides an opportunity to train nurse scientists in comparative and cost-effectiveness research, fields of scientific inquiry that employ innovative methods to generate knowledge aimed at improving quality and efficiency by informing the everyday decisions confronting clinicians, patients, purchasers, and policymakers.

Learn more about the CER2 Fellowship Program.

Center for Improving Palliative Care for Vulnerable Adults with MCC (CIPC)

Multiple Principal Investigators: Stone, Shang

The CIPC (NIH P20NR018072) provides expert guidance to nurse scientists in becoming leaders of interdisciplinary research teams that generate knowledge to inform how best to provide palliative care to vulnerable adults with multiple chronic conditions that is consistent with their personal preferences and reduces burdensome treatments and transitions.

Learn more about the Center for Improving Palliative Care for Vulnerable Adults with MCC (CIPC).

ImpAct of COVID-19 on CaRe TransitOns and Health OutcomeS for Vulnerable PopulationS in Nursing Homes and Home HealthCARE Agencies (ACROSS-CARE)

Multiple Principal Investigators: Shang, Stone

In this study (NIH 1R01AG074492), we will examine the impact of COVID-19 pandemic on care transitions between hospitals, home health agencies and nursing homes, as well as patient outcomes. The study also examines the effectiveness of infection prevention and control practices in home health agencies and nursing homes in reducing the impact of COVID-19.

Learn more about the ImpAct of COVID-19 on CaRe TransitOns and Health OutcomeS for Vulnerable PopulationS in Nursing Homes and Home HealthCARE Agencies (ACROSS-CARE) study. 

Disparities in Infection in Home Health and Patients/Caregivers' Perceptions (Dis-Infection in HHC)

Principal Investigator: Jingjing Shang, PhD, RN, OCN, FAAN

This study (AHRQ 1R01HS028637) will be the first to examine health disparities in infections in HHC, explore infection prevention and control-related knowledge, attitudes, practices among home healthcare patients and/or their caregivers and develop and pilot test a multi-modal intervention to improve infection prevention and control practices at home.

Learn more about the Disparities in Infection in Home Health and Patients/Caregivers' Perceptions (Dis-Infection in HHC) study. 

Infection Prevention in Home Health Care (InHOME)

Multiple Principal Investigators: Shang, Stone

In this study (NIH 5R01NR016865), we are investigating infections (respiratory, deep tissue, urinary tract, and intravenous catheter-related) and infection prevention and control infrastructure and policies in home health care (HHC) settings across the nation. This study will be the first comprehensive examination of infections and infection prevention and control in the HHC environment.

Learn more about the Infection Prevention in Home Health Care (InHOME) study. 

Study of Infection Management and Palliative Care at End-of-Life (SIMP-EL)

Principal Investigator: Patricia Stone, PhD, RN, FAAN, CIC

In this study (NIH 5R01NR013687), we are investigating the integration of infection control and management and palliative care processes in nursing homes across the nation and will characterize antibiotic use and hospital transfers at end-of-life. This study has the potential to make clinical and policy-relevant contributions by promoting resident-centered end-of-life care for millions of Americans.

Learn more about the Study of Infection Management and Palliative Care at End-of-Life (SIMP-EL).

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT)

Multiple Principal Investigators: Green, Smaldone

HABIT (NIH 5R01NR017206-02) is a five-site, four-year randomized control trial with overall goals of reducing barriers to Hydroxyurea use and improving medication adherence for youth 10-18 years with Sickle Cell Disease (SCD) through creation of a daily medication habit. The goal of the proposed multi-site study is to test the efficacy of the HABIT intervention at six months and sustainability of the effect at 12 months. The importance of the problem of poor medication adherence, use of community health workers to bridge the gap between health services and underserved parent-youth dyads affected by SCD, the strength of the science, the success of our multi-ethnic feasibility study and the potential application of study findings to youth with other serious chronic illnesses speak to the importance of this trial.